Health
Pfizer and BioNTech coronavirus vaccine accepted for rolling review in Canada – Motley Fool Australia
Health Canada will determine BNT162b2’s suitability for approval as clinical trial data comes in.
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
The coronavirus vaccine candidate being developed by Pfizer(NYSE: PFE) and BioNTech(NASDAQ: BNTX) is now undergoing its first regulatory review in North America. The two companies announced that their BNT162b2 has been accepted for a rolling review by Health Canada, that country’s healthcare regulatory authority.
A rolling review is one undertaken while a candidate is still in developme…
-
Noosa News21 hours agoRallies under way as nationwide support for Palestine surges
-
General21 hours agoTens of thousands protest in nationwide action against war in Gaza
-
General24 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General18 hours agoThousands flood cities demanding action on Palestine